{
    "organizations": [],
    "uuid": "8ca737cc4981815a16442a5040e85cac70449c94",
    "author": "",
    "url": "https://www.reuters.com/article/brief-ema-recommends-immediate-suspensio/brief-ema-recommends-immediate-suspension-recall-of-multiple-sclerosis-medicine-zinbryta-idUSFWN1QP07K",
    "ord_in_thread": 0,
    "title": "BRIEF-EMA Recommends Immediate Suspension, Recall Of Multiple Sclerosis Medicine Zinbryta",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 7, 2018 / 10:09 AM / Updated 30 minutes ago BRIEF-EMA Recommends Immediate Suspension, Recall Of Multiple Sclerosis Medicine Zinbryta Reuters Staff March 7 (Reuters) - EU Medicines Agency: * EMA RECOMMENDS IMMEDIATE SUSPENSION AND RECALL OF MULTIPLE SCLEROSIS MEDICINE ZINBRYTA * EMA RECOMMENDATION FOLLOWING 12 REPORTS OF SERIOUS INFLAMMATORY BRAIN DISORDERS WORLDWIDE, INCLUDING ENCEPHALITIS AND MENINGOENCEPHALITIS * EMA’S RECOMMENDATION TO SUSPEND ZINBRYTA AND RECALL THE PRODUCT IS BEING SENT TO THE EUROPEAN COMMISSION FOR A LEGALLY BINDING DECISION * PRELIMINARY REVIEW OF EVIDENCE INDICATES IMMUNE REACTIONS OBSERVED IN REPORTED CASES MAY BE LINKED TO USE OF ZINBRYTA‍​ Source text ID: ( bit.ly/2oWAUEF ) Further company coverage:",
    "published": "2018-03-07T12:09:00.000+02:00",
    "crawled": "2018-03-07T12:50:49.001+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "updated",
        "minute",
        "ago",
        "recommends",
        "immediate",
        "suspension",
        "recall",
        "multiple",
        "sclerosis",
        "medicine",
        "zinbryta",
        "reuters",
        "staff",
        "march",
        "reuters",
        "eu",
        "medicine",
        "agency",
        "ema",
        "recommends",
        "immediate",
        "suspension",
        "recall",
        "multiple",
        "sclerosis",
        "medicine",
        "zinbryta",
        "ema",
        "recommendation",
        "following",
        "report",
        "serious",
        "inflammatory",
        "brain",
        "disorder",
        "worldwide",
        "including",
        "encephalitis",
        "meningoencephalitis",
        "ema",
        "recommendation",
        "suspend",
        "zinbryta",
        "recall",
        "product",
        "sent",
        "european",
        "commission",
        "legally",
        "binding",
        "decision",
        "preliminary",
        "review",
        "evidence",
        "indicates",
        "immune",
        "reaction",
        "observed",
        "reported",
        "case",
        "may",
        "linked",
        "use",
        "source",
        "text",
        "id",
        "company",
        "coverage"
    ]
}